This inventor holds 3 USPTO granted patents. Top assignees: The Wistar Institute, The United States of America as Represented by the Department of Health. Active years: 1996-2002.
Company Filing History:
3 out of 246 
1 out of 1,217 
Years Active: 1996-2002
Title: Klara Berencsi: Innovator in Cytomegalovirus Research
Introduction
Klara Berencsi is a prominent inventor based in Rosemont, PA (US). She has made significant contributions to the field of virology, particularly in the study of human cytomegalovirus (HCMV). With a total of 3 patents to her name, her work has implications for both therapeutic and preventive measures against viral infections.
Latest Patents
Klara's latest patents include innovative DNA constructs aimed at combating HCMV. One of her notable inventions is a novel DNA molecule designed for in vitro and in vivo expression of HCMV proteins, including gB, pp65, and others. These plasmids are intended to induce immune responses to HCMV, potentially enhancing the efficacy of HCMV vaccines. Another significant patent focuses on methods for retarding the development of atherosclerotic lesions. This method involves administering an effective amount of an anti-viral composition directed against CMV, which may include conventional chemical anti-microbial pharmaceutics or immunogenic proteins.
Career Highlights
Throughout her career, Klara has worked with esteemed organizations such as The Wistar Institute and the United States of America as represented by the Department of Health. Her research has been pivotal in advancing our understanding of viral infections and their impact on human health.
Collaborations
Klara has collaborated with notable colleagues in her field, including Eva Gonczol and Csaba Kari. These partnerships have contributed to the success of her research endeavors and the development of her patents.
Conclusion
Klara Berencsi's innovative work in the field of cytomegalovirus research highlights her dedication to advancing medical science. Her patents reflect her commitment to finding solutions for viral infections and their associated health challenges.